Women with breast cancer are increasingly receiving multigene genetic testing rather than just screening for the BRCA mutations, new research suggests.
A new gene-editing technology enables scientists to make thousands of edits at once and track them with specific barcodes.
Older people are more susceptible to infection, cancer, and autoimmunity than younger people. This may be the result of our immune cells' receiving increasingly random marching orders as we age.
A biobank from the U.K. releases hundreds of thousands of anonymized medical records and genetic data to scientists, who used it to track down new links between genetics and disease.
In a proof-of-principle study, Stanford scientists and colleagues used the CRISPR/Cas9 system to modify genes in coral, suggesting that the tool could one day aid conservation efforts.
Stanford researchers develop a new way to track the growth of diverse tumor types, using gene editing and DNA barcoding.
Stanford’s Cancer Genetics Program helps assess families' hereditary cancer risks and guide patients to make informed choices about prevention and treatment.
The strange skeletal remains of a fetus discovered in Chile have turned up new insights into the genetics of some bone diseases, according to a new study.
A Stanford Medicine article examines CRISPR, the gene-editing technology, and addresses its potential to help with conditions such as sickle-cell disease.
Protein aggregates in young neural stem cells seem to echo those seen in neurodegenerative disease-- but could they actually be helpful? As the cells age, they become less able to process the aggregates and their ability to activate is dampened.
A new Clinical Genomics Program at Stanford will improve the diagnosis of rare genetic diseases, benefiting patients such as Tessa and Colton Nye.
Scientists have used genome editing to pinpoint genes that reveal information about ALS and may even protect against the degeneration of neurons.
Stanford's Russ Altman discussed the pharmgkb.org database — which matches genomes with medication information — at the recent Beckman Symposium on campus.
Researchers have assumed that "synonymous" mutations don't matter. Now it looks like they're among the most important for creating species diversity.
Stanford University School of Medicine researcher Matthew Porteus, MD, PhD, was one of three expert witnesses who spoke at a U.S. Senate committee hearing on …
Ron Davis, PhD, calls chronic fatigue syndrome (also known as myalgic encephalomyelitis, or ME/CFS) the “last major disease about which we know almost nothing.” That’s …
